Glucose B Braun (Glucose)

Glucose B Braun is employed in clinical practice for several intravenous indications related to energy provision and fluid management.

• Treatment of hypoglycemia when oral glucose is not feasible.
• Component of parenteral nutrition regimens to meet carbohydrate requirements.
• Fluid and electrolyte replacement in patients unable to tolerate oral intake.
• Diluent for the preparation of other intravenous medications.
• Support of osmotic balance during renal replacement therapy.
• Adjunct in emergency resuscitation protocols to quickly restore blood glucose levels.

When administered intravenously, Glucose B Braun may be associated with a range of physiological responses, some of which are expected and others that require clinical attention.

Common

• Transient hyperglycemia, especially in patients with impaired insulin response.
• Mild electrolyte shifts, such as slight decreases in serum potassium.
• Local irritation at the infusion site if the solution is hyperosmolar.
• Fluid overload in patients receiving large volumes.
• Slight increase in serum osmolality, usually clinically insignificant.

Serious

• Severe hyperglycemia leading to osmotic diuresis.
• Hyperosmolar hyperglycemic state (HHS) in susceptible individuals.
• Allergic reactions ranging from urticaria to anaphylaxis.
• Metabolic acidosis if administered in excess without appropriate monitoring.
• Intravenous extravasation causing tissue injury if administered improperly.

Clinicians should observe specific precautions when prescribing Glucose B Braun to ensure patient safety and optimal therapeutic outcomes.

• Verify blood glucose levels before and during infusion to avoid hyperglycemia.
• Adjust infusion rate in patients with renal or cardiac insufficiency to prevent fluid overload.
• Monitor electrolyte concentrations, particularly potassium and sodium, during therapy.
• Use aseptic technique to prevent contamination of the sterile solution.
• Assess for signs of allergic reaction, especially in patients with a history of carbohydrate hypersensitivity.
• Avoid rapid bolus administration unless clinically indicated.
• Document the concentration and total volume administered in the patient record.

Glucose B Braun may interact with other intravenous agents or systemic conditions, requiring careful consideration of concurrent therapies.

Avoid

• Co-administration with high‑dose insulin infusions without glucose monitoring, which can precipitate severe hypoglycemia.
• Simultaneous infusion of hypertonic saline solutions that may exacerbate hyperosmolar states.
• Mixing with calcium-containing solutions can cause precipitation; administer separately.

Use with caution

• Concurrent use of potassium‑sparing diuretics; monitor serum potassium closely.
• Administration alongside other carbohydrate‑containing parenteral solutions; adjust total carbohydrate load.
• Patients receiving total parenteral nutrition; balance glucose infusion rates to avoid excess calories.
• Use in patients with renal failure; monitor fluid balance and electrolytes.